Greg Koski
Biographic Data
| ID | 6763952 |
|---|---|
| NAME | Greg Koski |
| GIVEN NAMES | Greg |
| FAMILY NAME | Koski |
| SIGNATURE | KOSKI G |
| AFFILIATIONS | Massachusetts General Hospital |
| ORCID | 0000-0002-5859-3625 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2003 |
| LATEST PUBLICATION YEAR | 2008 |
| H-INDEX | 1 |
Opinions of IRB Members and Chairs regarding Investigators' Relationships with Industry
THE EFFECTS OF CONFLICTS OF INTEREST on the conduct of human research have been roundly debated, but less attention has been paid to the role of Institutional Review Boards (IRBs) in their identification and management. Government and private policy recommendations disagree about IRBs' responsibility in this area. A survey focusing on respondents' attitudes and behaviors regarding consideration of investigator and institutional financial relation…
Pharma PR or Medical Education
Harry A. Sweeney, Joel M. Roselin, Christy A. Rentmeester, Michael J. Oldani, Bert W. Rein, Greg Koski, Pharma PR or Medical Education?, The Hastings Center Report, Vol. 35, No. 2 (Mar. - Apr., 2005), pp. 4-7
FDA and the Life-Sciences Industry: Business as Usual
On April 15, while most Americans were signing and mailing their 1040s, Rep. Joe Barton (R-TX.), chair of the House Energy and Commerce Committee, issued a press release in which the Food and Drug Administration admitted, for the first time, that an important report regarding concerns for the safety of children taking prescription antidepressants had not been released to the public. As the complex story of the FDA's oversight on antidepressants u…
Beyond Compliance… Is It Too Much to Ask
Opinions of IRB Members and Chairs regarding Investigators' Relationships with Industry
THE EFFECTS OF CONFLICTS OF INTEREST on the conduct of human research have been roundly debated, but less attention has been paid to the role of Institutional Review Boards (IRBs) in their identification and management. Government and private policy recommendations disagree about IRBs' responsibility in this area. A survey focusing on respondents' attitudes and behaviors regarding consideration of investigator and institutional financial relation…
Beyond Compliance… Is It Too Much to Ask
FDA and the Life-Sciences Industry: Business as Usual
On April 15, while most Americans were signing and mailing their 1040s, Rep. Joe Barton (R-TX.), chair of the House Energy and Commerce Committee, issued a press release in which the Food and Drug Administration admitted, for the first time, that an important report regarding concerns for the safety of children taking prescription antidepressants had not been released to the public. As the complex story of the FDA's oversight on antidepressants u…
Pharma PR or Medical Education
Harry A. Sweeney, Joel M. Roselin, Christy A. Rentmeester, Michael J. Oldani, Bert W. Rein, Greg Koski, Pharma PR or Medical Education?, The Hastings Center Report, Vol. 35, No. 2 (Mar. - Apr., 2005), pp. 4-7
Opinions of IRB Members and Chairs regarding Investigators' Relationships with Industry
THE EFFECTS OF CONFLICTS OF INTEREST on the conduct of human research have been roundly debated, but less attention has been paid to the role of Institutional Review Boards (IRBs) in their identification and management. Government and private policy recommendations disagree about IRBs' responsibility in this area. A survey focusing on respondents' attitudes and behaviors regarding consideration of investigator and institutional financial relation…
Business (3 works) · Psychology (3 works) · Medicine (2 works) · Pharmaceutical industry and healthcare (2 works) · Academic integrity and plagiarism (1 works) · Ask price (1 works) · Conflict of interest (1 works) · Ethics in Clinical Research (1 works) · Evaluation and Performance Assessment (1 works) · Family medicine (1 works)